Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term term-follow-up. Found 10 abstracts

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Kelly Marcom P, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw. 2017 Apr;15(4):433-51.
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB. Testicular Cancer Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):502-35.   PMCID: not NIH funded
Thomay AA. Nonsurgical Adjunctive Treatment and Its Effects on the Axilla. Current Problems in Cancer. 2012 Sep;36(5):305-24.   PMCID: not NIH funded
Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, Meron Aj VP. Esophageal and Esophagogastric Junction Cancers. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):830-+.   PMCID: not NIH funded
Blay JY, von Mehren M, Blackstein ME. Perspective on Updated Treatment Guidelines for Patients With Gastrointestinal Stromal Tumors. Cancer. 2010 Nov;116(22):5126-37.   PMCID: NIH funded
Belinsky MG, Skorobogatko YV, Rink L, Pei JM, Cai KQ, Vanderveer LA, Riddell D, Merkel E, Tarn C, Eisenberg BL, von Mehren M, Testa JR, Godwin AK. High Density DNA Array Analysis Reveals Distinct Genomic Profiles in a Subset of Gastrointestinal Stromal Tumors. Genes Chromosomes & Cancer. 2009 Oct;48(10):886-96.   PMCID: PMC2830286
Whittemore AS, Stearman B, Venne V, Halpern J, Felberg A, McGuire V, Daly M, Buys SS. No evidence of familial correlation in breast cancer metastasis. Breast Cancer Research and Treatment. 2009 Dec;118(3):575-81.   PMCID: PMC 2783315
Haluszka O, Tokar JL, Greenwald BD. Endoscopic oncology. Current Problems in Cancer. 2005 Mar;29(2):39-112.
McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Practice & Research in Clinical Gastroenterology. 2005 Feb;19(1):3-23.
Morris GJ, Millenson MM, Padavic-Shaller K, Wang H, Rogatko A, Clyde J, Boyd RL, Yeslow G, Halbherr T, Schilder RJ, Smith MR. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphorna. Haematologica. 2004 Dec;89(12):1484-91.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term term-follow-up

term-follow-up lymph-node dissection chemotherapy NCCN Guidelines imatinib mesylate positron-emission-tomography NCCN Clinical Practice Guidelines surgical-management endoscopic mucosal resection randomized clinical-trial multidisciplinary care comparing radical-mastectomy germ cell tumors radiation-therapy progression-free survival maintenance therapy final analysis alpha-fetoprotein c virus first-line therapy hepatitis C phase-ii trial cisplatin hepatocellular carcinoma multiple-myeloma kit activation dose imatinib sponsored-working-group c-kit individual patient data combined-modality nonseminoma biologic therapy cisplatin-based chemotherapy esophageal randomized controlled-trial incidence testicular cancer stage-i seminoma germ-cell tumors papillary-mucinous tumor women 70 years therapy squamous-cell carcinoma indiana-university experience conservative surgery chorionic gonadotropin mutations cryptogenic gemcitabine organ progression 1995 ow wh-v274-p474 prognostic implications phase-iii interstitial-cells genetic-variation aromatase inhibitors phase helical ct survival cooperative-oncology-group phase-ii lumpectomy plus tamoxifen fine-needle-aspiration human bile-duct cancer lactate dehydrogenase hepatitis B virus Breast cancer Familial correlation aflatoxin B-I virus porphyria-cutanea-tarda 1993 bruin mjfm-british journal of urology-v71-p336 potential therapeutic target unresectable pancreatic-cancer arbeitsgemeinschaft internistische onkologie young-adults Metastatic potential randomized-trial intensity-modulated radiotherapy 2006 giorgi u-eur urol-v50-p1038 of-the-literature fulvestrant 500 mg primary sclerosing cholangitis 2002 oo r-can j urol-v9-p1479 high-grade dysplasia preservation expanding metal stents standard axillary treatment resection primary liver-cancer carcinoma chemoradiation breast anastrozole 1 mg celiac plexus block surgical adjuvant tyrosine-kinase inhibitor 2010 ung pw-j clin oncol-v28 disease alpha-1-antitrypsin deficiency gist salvage chemotherapy minimally invasive esophagectomy diabetes-mellitus risk-factor regression chronic lymphocytic-leukemia 2011 ung p-j natl cancer i-v103-p194 cirrhosis medical-research-council model seminoma early gastric-cancer stromal gastrointestinal-tumors-imatinib-practice guideline-protein tyrosine-kinases-sunitinib alpha-interferon fludarabine-low-grade NHL hepatitis-b-virus advanced follicular lymphoma polymorphisms high-dose nonalcoholic steatohepatitis surgery surgical adjuvant breast combined modality therapy early breast-cancer targeted therapy 2002 ung p-can j urol-v9-p1637
Last updated on Friday, January 03, 2020